Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2373-8057
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progression ; volume:5 ; number:1 ; day:3 ; month:5 ; year:2019 ; pages:1-8 ; date:12.2019
npj Parkinson's Disease ; 5, Heft 1 (3.5.2019), 1-8, 12.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-019-0079-3
- URN
-
urn:nbn:de:101:1-2019070509334271310597
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pereira, Joana B.
- Weintraub, Daniel
- Chahine, Lana
- Aarsland, Dag
- Hansson, Oskar
- Westman, Eric
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
Factors associated with fear of falling in people with Parkinson’s disease
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process
18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Novel insights regarding the measurement properties of the SCOPA-AUT
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
Factors associated with fear of falling in people with Parkinson’s disease
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process
18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Novel insights regarding the measurement properties of the SCOPA-AUT
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
Factors associated with fear of falling in people with Parkinson’s disease
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Effects of certain pre-analytical factors on the performance of plasma phospho-tau217
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Characterization of degradation and heterozygote balance by simulation of the forensic DNA analysis process
18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
Cognitively normal women with Alzheimer’s disease proteinopathy show relative preservation of memory but not of hippocampal volume
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies